Xenon Pharmaceuticals
XENE
XENE
31 hedge funds and large institutions have $27.5M invested in Xenon Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
21% less funds holding
Funds holding: 39 → 31 (-8)
78% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 9
Holders
31
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$442K | |
| 2 | +$291K | |
| 3 | +$206K | |
| 4 |
DMK
David M. Knott
|
+$133K |
| 5 |
Renaissance Technologies
New York
|
+$76.9K |
Top Sellers
| 1 | -$2.28M | |
| 2 | -$402K | |
| 3 | -$259K | |
| 4 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
-$99K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$61K |